Dry extracts of ginkgo leaves are considered promising drugs for improving age-related cognitive impairment. A study compared the phytochemical composition of fourteen medicines containing ginkgo that have been approved by German health authorities for this indication and revealed some considerable differences in the proportion of proanthocyanidins (PACs).
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- InFo NEUROLOGIE & PSYCHIATRIE
- PHYTOTHERAPIE PRAXIS
Related Topics
You May Also Like
- COPD therapy
Drug therapy – Update 2025
- Pulmonary hypertension
PH and lung diseases
- IBDmatters - Synergy effects for IBD pathways
How combination therapies lead to better treatment results
- Focus on prevention
Colorectal cancer screening – an update
- Chronic hand eczema
Topical pan-JAK-i vs. systemic retinoid: head-to-head study
- Study report
Long-term data on CFTR modulators in children with cystic fibrosis
- Multiple sclerosis
Multiple sclerosis 2025: New strategies against progression and the role of microglia
- A syndrome between decompensation and chronification